Granite Investment Partners’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
+58,828
New +$1.66M 0.08% 163
2023
Q4
Sell
-395,810
Closed -$17.3M 262
2023
Q3
$17.3M Buy
395,810
+860
+0.2% +$42K 0.73% 49
2023
Q2
$19.5M Sell
394,950
-3,628
-0.9% -$167K 0.78% 45
2023
Q1
$16.5M Sell
398,578
-2,666
-0.7% -$111K 0.69% 59
2022
Q4
$17.8M Sell
401,244
-5,947
-1% -$248K 0.74% 52
2022
Q3
$15.9M Buy
407,191
+185,481
+84% +$8.49M 0.69% 56
2022
Q2
$9.06M Buy
+221,710
New +$10.5M 0.38% 96

Other funds holding ATRC

Granite Investment Partners's ATRC Position: Q2 2026 in Review

Granite Investment Partners opened a new position in AtriCure (ATRC) in Q2 2026: 58,828 shares worth $1.65M. The stake represents 0.08% of the portfolio and ranks #163 among its holdings. This is a return to the name: Granite Investment Partners previously reported a position in ATRC as recently as Q3 2023.

Granite Investment Partners first reported a position in ATRC in Q2 2022 and has held it in 7 quarters since. The position peaked at $19.5M in Q2 2023. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Granite Investment Partners held 58,828 shares of AtriCure worth $1.65M as of Q2 2026.
  • AtriCure was a new Granite Investment Partners position in Q2 2026.
  • AtriCure made up 0.08% of Granite Investment Partners's portfolio in Q2 2026, its #163 holding.
  • Granite Investment Partners first reported a position in AtriCure in Q2 2022 and has held it in 7 quarters since.
  • Granite Investment Partners's AtriCure position peaked at $19.5M in Q2 2023.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Granite Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.